SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-17-024607
Filing Date
2017-05-04
Accepted
2017-05-04 17:12:07
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 v466060_s3.htm S-3 218455
2 EXHIBIT 5.1 v466060_ex5-1.htm EX-5.1 13886
3 EXHIBIT 23.1 v466060_ex23-1.htm EX-23.1 2556
4 EXHIBIT 23.2 v466060_ex23-2.htm EX-23.2 2412
5 EXHIBIT 23.3 v466060_ex23-3.htm EX-23.3 5044
6 GRAPHIC image_004.jpg GRAPHIC 3448
7 GRAPHIC image_003.jpg GRAPHIC 3823
8 GRAPHIC image_005.jpg GRAPHIC 2567
9 GRAPHIC image_008.jpg GRAPHIC 64796
10 GRAPHIC image_001.jpg GRAPHIC 2950
11 GRAPHIC image_002.jpg GRAPHIC 2953
  Complete submission text file 0001144204-17-024607.txt   355148
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-217673 | Film No.: 17815088
SIC: 8731 Services-Commercial Physical & Biological Research